Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tianjin Institute of Pharmaceutical Research discloses new agents for diabetes

Sep. 1, 2011

Bionovo reports data from Menerba trial in postmenopausal women

Aug. 31, 2011

Aeterna Zentaris reports encouraging phase III data on AEZS-130

Aug. 31, 2011

Preclinical program of afamelanotide for erythropoietic protoporphyria completed

Aug. 31, 2011

Chinese institute presents novel sodium/glucose cotransporter 2 inhibitors

Aug. 31, 2011

Takeda initiates two phase II trials of TAK-385 in Japan

Aug. 29, 2011

Phase III trial compares Ferinject and Venofer in IBD-associated iron deficiency anemia

Aug. 29, 2011

Boehringer Ingelheim and Lilly obtain European approval for linagliptin

Aug. 26, 2011

Kowa gains rights to anagliptin in two Asian countries

Aug. 26, 2011

Allergan patents new cannabinoid CB2 receptor agonists

Aug. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...